Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Antiinflammatory compounds with macrolide structure designed by Zambon

Sep. 4, 2000

ERS highlights: orazipone prevents eosinophilia in animal models of lung inflammation

Sep. 4, 2000

Beneficial effects of PAF antagonist in patients with bronchial asthma

Sep. 4, 2000

Magainin awarded SBIR Grant for development of asthma therapy

Sep. 1, 2000

Neutrophil elastase inhibitors may actually target an important host defense enzyme

Sep. 1, 2000

Asthma research at Bayer targets inhibition of MMP

Aug. 31, 2000

Aventis reports MMP-12 inhibitors for the treament of emphysema in smokers

Aug. 31, 2000

Rigel and Novartis establish drug discovery agreement for respiratory therapies

Aug. 29, 2000

Vitamin D3 derivatives claimed by Teijin for treatment of cystic fibrosis

Aug. 29, 2000

Potent, selective muscarinic M3 receptor antagonists patented by Mitsubishi-Tokyo

Aug. 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...